Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

58298 results about "Therapeutic effect" patented technology

Therapeutic effect refers to the response(s) after a treatment of any kind, the results of which are judged to be useful or favorable. This is true whether the result was expected, unexpected, or even an unintended consequence. An adverse effect (including nocebo) is the converse and refers to harmful or undesired response(s). What constitutes a therapeutic effect versus a side effect is a matter of both the nature of the situation and the goals of treatment. No inherent difference separates therapeutic and undesired side effects; both responses are behavioral/physiologic changes that occur as a response to the treatment strategy or agent.

Apparatus and methods for the treatment of avian influenza with ultrasound

The method and device of the present invention for the treatment of avian influenza and other viruses, bacteria, and infectious agents with ultrasonic waves includes a generator and a transducer to produce ultrasonic waves. The ultrasonic transducer has a specially designed ultrasound tip that is able to radiate ultrasound energy toward the body of the target animal or human at a level higher than a traditional ultrasound tip. The apparatus delivers ultrasonic energy without contacting the target through an air / gas medium or through a spray, or by contacting the target with or without a coupling medium. The ultrasonic waves provide a therapeutic effect such as destroying viruses, bacteria, or other infectious agents, increasing blood flow, or stimulating the immune system, etc; additionally, breathing ability is enhanced through the ultrasonic delivery of a medicament to the target's lungs.
Owner:BABAEV EILAZ

Automatic rise time adjustment for bi-level pressure support system

An apparatus and method for a bi-level positive airway pressure support in which the rise time from the expiratory positive airway pressure to the inspiratory positive airway pressure is automatically controlled by the pressure support system. The pressure support system includes a sensor, a control system, and a pressure generating system. The sensor monitors the patient's respiration to detect respiratory events, such as an apnea, hyponea or other disturbance, and the control system responds to the sensor information to adjust the rise time from the expiratory positive airway pressure to the inspiratory positive airway pressure gas pressure to maximize patient comfort and pressure support treatment effectiveness.
Owner:RIC INVESTMENTS LLC

System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram

Disclosed is a system and method of assessing the efficacy of treatment of neurological or psychological disorders. The preferred embodiment uses at least two surface electrodes to acquire EEG signals from the surface of a patient's body, a processor for computing from the EEG signals various features and indices that are representative of the patient's neurological or psychological state. Changes in these parameters may be used to assess the efficacy of treatment and to modify the treatment to optimize the resultant patient state.
Owner:TYCO HEALTHCARE GRP LP

Interchangeable tips for medical laser treatments and methods for using same

A typical treatment system for use with tip embodiments includes an optical energy source, such as, for example, a laser. A set of tips may be interchangeably attached to the treatment system, for example to alter the system parameters and the treatment provided through the individual tips. Embodiments of the present invention include tips with a security chip and / or a memory. A security chip protects the treatment system from use with unauthorized tips, and the memory stores information about the tips and / or the treatment system to enhance the treatment
Owner:RELIANT TECH INC

Composition comprising an agent providing a signal, an implant material and a drug

InactiveUS20060177379A1Facilitated releaseAvoid impairment of material compositionMaterial nanotechnologySurgeryTreatment effectBULK ACTIVE INGREDIENT
The present invention relates to compositions or combinations of materials for non-degradable and degradable implantable medical devices with regard to the setup of their signal generating properties and control of their therapeutic effectiveness, as well as to a method for the control of degradation of degradable or partially degradable medical devices composed like this, based on their signal generation, and to a method for supervision of their therapeutic effectiveness and / or the release of therapeutically active ingredients from such devices.
Owner:CINVENTION AG

Interactive transcutaneous electrical nerve stimulation device

InactiveUS20070276449A1Quickly and easily changedEffectively treats area greatExternal electrodesNervous tissueTherapeutic Area
A wireless, handheld electrical therapy device delivers electrical pulses to a treatment area of a patient. In one embodiment, the device comprises a microcontroller-based pulse generator circuit selectively operable in a plurality of therapeutic modes. The device comprises an ergonomic housing adapted to be comfortably grasped by a user. A plurality of electrodes are disposed on a surface of the housing. In operation, a user brings the electrodes into contact with a patient's skin at a location on the patient to be treated. Electrical pulses are delivered between the electrodes, thereby electrically stimulating neural tissue at the treatment location. In one embodiment, the device is operable in a manual mode wherein the user selects from among a plurality of therapeutic regimens each corresponding to a set of predetermined operational parameters. Among the variable operational parameters are pulse amplitude, frequency, duration, damping, and shape. In another embodiment of the invention, the device is operable in an automatic mode wherein electrical conditions at the skin surface are periodically sensed and the operational parameters automatically adjusted to achieve optimal therapeutic effectiveness.
Owner:MED LECTRIC CORP

Inhibition of irritating side effects associated with use of a topical ophthalmic medication

This invention relates to a method of reducing an irritating or adverse side effect associated with the topical use of an active ophthalmic drug comprising incorporating an effective amount of a cyclodextrin or cyclodextrin derivative into a formulation to complex the active drug such that the concentration of the free active drug is reduced below a tolerable threshold, and incorporating an effective amount of a viscosity increasing agent in said formulation such that the bioavailability of said drug is high enough to be therapeutically effective, wherein the cyclodextrin or cyclodextrin derivative is not required to solubilize the active drug. Another aspect of this invention relates to topical ophthalmic formulations comprising an active drug, a cyclodextrin or cyclodextrin derivative, and a viscosity-enhancing agent, in effective amounts as stated above.
Owner:ALLERGAN INC

Vacuum device and method for treating tissue adjacent a body cavity

InactiveUS6923754B2Shorter treatmentGood correlationStentsSurgeryTreatment effectMedicine
Devices and methods are provided for applying vacuum near to devices for delivering treatments to tissue adjacent a body cavity, effective to draw adjacent tissue near to such devices and to enhance treatment of the tissue. Body cavities include natural body cavities and cavities remaining after removal of tissue such as cancerous tissue. A device may include an inner balloon assembly with an inflation conduit. A sheath assembly having a fluid-permeable sheath wall may enclose the inner balloon assembly. Vacuum applied to the space between the sheath and the inner balloon is useful to draw tissue into contact with the device, improving treatment effectiveness. Methods for treating tissue with such devices and systems are also provided. Treatments may include providing radioactive material for radiation treatment, providing chemotherapeutic material for chemotherapy, providing thermal treatment, and combinations thereof. Systems may include devices of the invention and a vacuum source.
Owner:HOLOGIC INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products